Literature DB >> 15626767

Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists.

Michelle N Bradley, Peter Tontonoz.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15626767     DOI： 10.1161/01.ATV.0000152727.69018.61

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  3 in total

1.  Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 Promote Cholesterol Excretion Through the Up-Regulation of ABCG5/8 in Caco-2 Cells.

Authors:  Hong-Sup Yoon; Jae-Hyun Ju; Hannah Kim; Jieun Lee; Hyun-Joon Park; Yosep Ji; Hyeun-Kil Shin; Myoung-Sool Do; Jung-Min Lee; Wilhelm Holzapfel
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

2.  LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.

Authors:  Jonathan E Feig; Ines Pineda-Torra; Marie Sanson; Michelle N Bradley; Yuliya Vengrenyuk; Dusan Bogunovic; Emmanuel L Gautier; Daniel Rubinstein; Cynthia Hong; Jianhua Liu; Chaowei Wu; Nico van Rooijen; Nina Bhardwaj; Michael Garabedian; Peter Tontonoz; Edward A Fisher
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

Review 3.  Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.

Authors:  Ryan D Welch; Cyrielle Billon; McKenna Losby; Gonzalo Bedia-Diaz; Yuanying Fang; Amer Avdagic; Bahaa Elgendy; Thomas P Burris; Kristine Griffett
Journal:  Metabolites       Date:  2022-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.